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The differential effect of contrast agents 
on endothelial cell and smooth muscle cell 
growth in vitro 
Carol J. Sawmiller, MD, Richard J. PoweR, MD, Mohammed Quader, MD, 
Stanley J. Dudrick, MD,  and Bauer E. Sumpio, MD,  PhD, New Haven, Conn. 
Purpose: This study was designed to evaluate the effects of ionic and nonionic contrast 
agents on endothelial cell (EC) and smooth muscle cell (SMC) proliferation, and to 
determine the role of osmolality as the etiology of these effects. 
Methods: Cultured bovine aorta EC and SMC were exposed to ionic (iothalamate meg- 
lumine) or nonionic (ioversol or iopamidol) contrast, or varying osmolar solutions of 
mannitol, for periods of 1, 3, 5, 10, or 20 minutes. Cells were then incubated in growth 
media at 37 ° C and proliferation and structure were assessed 1, 3, 5, and 7 days later. 
Results: Both EC and SMC showed decreased proliferation after brief exposure to both 
ionic and nonionic ontrast. Proliferation was markedly decreased at24 hours after expo- 
sure, and began to recover by day 3 after exposure. EC showed a significant decrease up 
to 7 days after exposure to ionic contrast (p < 0.03), whereas SMC showed a significant 
decrease up to 7 days after exposure to nonionic ontrast (p < 0.001). The decrease in pro- 
liferation was directly dependent on the length of exposure to the contrast and the con- 
centration of the contrast. EC proliferation decreased in proportion to increasing osmo- 
lality of the test solution (p < 0.05). SMC proliferation did not show a decrease propor- 
tional to osmolality. No change was observed in cell viability as assessed by LDH activity 
studies. After contrast exposure, bare areas with no cells present were noted in the previ- 
ously confluent EC and SMC culture wells. Cell structure was altered immediately after 
exposure to contrast, with normal structure recovered by 24 hours after exposure. 
Conclusion: This study demonstrates that brief exposure to contrast agents injures EC 
and SMC, altering their structure and decreasing proliferation for up to 7 days in vitro. 
This response is both dose and time dependent. EC are more severely affected by ionic 
contrast, and SMC are more severely affected by nonionic ontrast. EC injury appears 
to be mediated by the osmolar effect of the contrast, but the effects of contrast on SMC 
seem to be due to a different mechanism. (J Vasc Surg 1998;27:1128-40.) 
Physicians treating patients with vascular disease 
rely on contrast enhanced x-ray films to define the 
anatomy of the vasculature and the extent of disease, 
and to guide operative therapy. However, intravas- 
cular injection of  contrast agent may lead to adverse 
effects, such as pain, hemolysis, thrombosis, vasodi- 
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lation, and hypotension3 -3 These reactions are seen 
more frequently after the administration f  ionic 
contrast compared with nonionic contrast. 4 The 
pathophysiologic mechanism responsible for the 
toxicity of contrast remains unclear, but injury to the 
endothclium ay play a role. 
Previous tudies have shown contrast to bc direct- 
ly toxic to the vascular endothelium. 5-9 After in vivo 
contrast exposure, intact segments of aorta demon- 
strated endothelial cell (EC) shrinkage, expansion of 
intracellular clefts, and areas in which the endothelial 
layer had separated and lifted off the subendotheli- 
um. 6 By using a silver staining method, Nyman ct al.7 
showed more EC damage induced after exposure to 
ionic contrast, compared with nonionic ontrast. This 
difference could only be partially attributed to the 
higher osmolality of the ionic contrast, as solutions 
that were isosmolar to the ionic contrast induce less 
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Table I. Characteristics of contrast agents used in this study. 
Trade name Conray Optiray Isovue 
Contrast agent Iothalamate meglumine 60% Ioversol 68% Iopamidol 76% 
Ionicity Ionic Nonionic Nonionic 
Bound iodine 282 mg/ml 320 mg/ml 370 mg/ml 
Osmolality 1400 mOsm/kg 702 mOsm/kg 796 mOsm/kg 
T~ alpha-distribution 10 minutes 20 minutes 10-15 minutes 
Tg beta-elimination 90 minutes 90 minutes 120 minutes 
Viscosity at 37 ° 4 cP 5.8 cP 9.4 cP 
pH 6.5-7.7 6.0-7.4 6.5-7.5 
Figures for the above characteristics are th manufacturers specifications, cP = centiPoise. 
cellular injury. 7-9 By using Chromium 51 release to 
assess cell injury, Laerum 8 demonstrated immediate 
release on exposure to contrast, with no increased 
release 24 hours after exposure, supporting the theo- 
ry that contrast-induced cellular injury is an acute 
process. Cellular repair, however, as measured by 
increased DNA synthesis, continues for 3 to 10 days 
after exposure. 10 The mechanism of these effects is 
unclear, but has been postulated to be related to the 
hyperosmolar nature of contrast agents. 
The objective of  this study was to assess the 
effect of exposure to ionic and nonionic contrast on 
EC and smooth muscle cell (SMC) proliferation and 
structure. The effect of varying concentrations of
contrast and varied exposure times was assessed. 
Hyperosmolar-induced cellular injury was investi- 
gated as a possible mechanism for the adverse effects 
of contrast agents. 
MATERIALS AND METHODS 
Chemicals. Three contrast agents were com- 
pared (Table I), iothalamate meglumine (Conray, 
MaUinclcrodt Medical, Inc., St. Louis, Mo.), an ionic 
contrast, and ioversol (Optiray 320, Mallinckrodt 
Medical, Inc., St. Louis, Mo.) and iopamidol (Isovue 
370, Bracco Diagnostics Inc., Squibb and Sons Inc., 
New Brunswick, N.J.) two nonionic contrast agents 
with an osmolality about half that of  iothalamate 
meglumine. 
A 1400 mOsm/kg solution of mannitol (Sigma 
Chemical, St. Louis, Mo., FW 18.2) was diluted in 
growth media to create 700 and 350 mOsm/kg  
solutions. Mannitol is neither tal~en up nor metabo- 
lized by EC or SMC, 11 so its effects on cell function 
are thought o be due primarily to its osmolality. 
Cell Culntre. Bovine aortic EC and SMC were 
prepared from bovine aorta as previously described 12 
and passage 2 through 8 cells were used. Cells were 
grown to confluence in 75 cm 2 flasks in humidified 
37 ° C incubators. EC were maintained in Dulbecco's 
Modified Eagle Medium (DMEM), 10% fetal bovine 
serum, 0.2% deoxycytidine-thymidine, and1% PCN, 
streptomycin, amphotericin; SMC were maintained 
in DMEM, 10% fetal bovine serum, and I% PCN, 
streptomycin, amphotericin. 
Prol iferation Studies. EC and SMC were plat- 
ed in separate 12-well plates (well diameter 22 mm) 
at 60,000 cells per well for all experiments except for 
studies more than 7 days. Cell wells were seeded at 
a density of 20,000 cells per well for 7-day studies to 
avoid over confluence. The cells were allowed to 
attach for 24 hours before experimentation. 
Six wells for each experiment were washed with 
phosphate buffered solution (PBS), trypsinized, and 
an aliquot of  the cell suspension was counted 
(Coulter counter, Model 2M, Hiahleah, Fla.) to 
provide a baseline, preexposure count. Cell wells 
were washed with PBS twice and 0.5 ml of contrast 
media (iothalamate, ioversol, or iopamidol) in vary- 
ing concentrations was added per well. Cells were 
exposed to full strength, ½ strength, or ¼ strength 
contrast diluted in growth media. The cells were 
incubated at 37 ° C for either 1, 3, 5, 10, or 20 min- 
utes. Contrast was then aspirated and the cell wells 
were washed with PBS twice to remove all contrast. 
Growth media was replaced and the cells were incu- 
bated at 37 ° C. 
Following the same protocol,  EC and SMC 
were exposed to 0.5 mls of  1400, 700, or 350 
mOsm/kg  mannitol solution for 10 minutes. 
Control  cells were washed with PBS twice and 
growth media was replaced. Fresh growth media 
was replaced in all groups every 2 days. Cell prolif- 
eration was assessed 1 and 3 days after exposure. 
For each time point, six wells per group were 
washed with PBS, trypsinized, and the cell suspen- 
sion counted in a Coulter counter. The six well 
counts were averaged for each time point for each 
experiment. Lactate dehydrogenase (LDH) activity 
in the media was measured with a commercially 
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Fig. 1. Comparison of cell proliferation after exposure to 
three different contrast agents. Cells were exposed to full 
strength contrast for 10 minutes. One representative 
experiment is shown. Data are mean + SEM. *p < 0.05 
compared with control. Top graph, EC proliferation. 
Conray inhibited proliferation to greater degree than 
Optiray or Isovue. (p < 0.05). Bottom graph, SMC prolif- 
eration. Exposure to all contrast agents significantly 
decreased proliferation at day 1 and 3, with exposure to 
Optiray causing greatest effect. (p < 0.05 compared with 
Conray and Isovue.) 
available kit (Sigma Chemical, St. Louis, Mo.) 
before exposure, 1 hour after exposure, when max- 
imum cell injury was noted, and 72 hours after 
exposure. 
Cell Structure Studies. Cells were fixed in 
3.7% formaldehyde immediately, 1 hour, 24 hours, 
and 72 hours after a lO-minute xposure to contrast. 
The cells were then stained with 0.1% crystal violet 
(Sigma Chemical, St. Louis, Mo.) for 1 to 2 minutes 
and viewed with an Olympus BH phase contrast 
photomicroscope (Olympus Optical, Tokyo, Japan). 
Statistics. All experiments were performed in at 
least triplicate. Data are reported as mean -+ SEM. 
Student test or analysis of variance with post hoc 
testing was used where appropriate. A p < 0.05 was 
considered significant. 
RESULTS 
Proliferation Studies. The effect of contrast on 
EC proliferation is shown in Fig. 1, top graph. All 
graphs represent a typical experiment. All experiments 
were repeated in at least triplicate, with consistent 
results. EC exposed to Conray had a 58.3% reduction 
in cell population by day 1 after exposure compared 
with control cells (p < 0.03) and was sustained for up 
to 7 days. Optiray exposure decreased c llnumber 
32.5% (p < 0.05) 1 day after exposure and 28.8% (p < 
0.05) 3 days after exposure, but only 5.3% (p = NS) 
compared with control cells 7 days after contrast 
exposure. Isovue significantly decreased cell number 
28.2% and 28.1% 1 and 3 days after exposure (p < 
0.05), but did not decrease cell number to a signifi- 
cant degree 7 days after exposure (15.6%), as scen 
with Conray. There was no significant difference 
between the effect of Optiray compared with Isovue. 
The effect of contrast on SMC proliferation is
shown in Fig. 1, bottom graph. SMC exposed to 
Optiray showed a significant 68.1% decrease in num- 
ber I day after exposure, a 70.2% decrease 3 days after, 
and a 63.7% decrease in cell number 7 days after expo- 
sure compared to control cells (p < 0.0001). Cortray 
exposure decreased proliferation 24.6% by day 7 (p < 
0.05), but Isovue exposure did not significantly 
reduce cell number 7 days after exposure (16.5%). 
LDH activity in the EC and SMC media (Fig. 2) 
remained constant before and after a 10-minute 
exposure to all three contrast agents and was not sig- 
nificandy different from control cells at 1 or 72 
hours after exposure. LDH activity was significantly 
less than positive control cells (EC or SMC treated 
with NaOH to stimulate cell death and LDH 
release) (p < 0.00001 ). 
Effect of  Exposure Time to Contrast. Both 
EC and SMC proliferation were significantly 
reduced when their exposure time to Conray con- 
trast was prolonged as shown in Fig. 3. At 24 hours 
after exposure to contrast, the effect of contrast is
directly proportional to exposure time. Fig. 3 
demonstrates that after a 1-minute exposure, EC 
number was decreased 5.0% (NS). A 3-minute xpo- 
sure reduced cell number 15.1% compared with con- 
trol cells (p < 0.05), 5-rninute exposure reduced cell 
number 25.0% (p < 0.05), 10-minute exposure 
decreased cell number 34.8% (p < 0.05), and 20- 
minute exposure reduced cell proliferation 43.1% (p 
< 0.05). By day 3 after exposure, cells with a 10- 
minute exposure time to contrast show a 12.5% 
decrease (p < 0.05) and the 20-minute exposure 
time show a 30.7% decrease (p < 0.05). Exposures of 
1, 3, and 5 minutes did not result in significantly 
reduced proliferation 3 days after exposure. 
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SMC proliferation shows a similar pattern (Fig. 
3, bottom graph). At 24 hours, although prolifera- 
tion is decreased 24.0% after a 1-minute exposure 
period, 32.4% after a 3-minute xposure, and 38.6% 
after a 5-minute period, this was not statistically sig- 
nificant (p > 0.10). After 10- and 20-minute xpo- 
sures, SMC number is significantly decreased 49.2% 
and 64.3% (p < 0.05). Three days after contrast 
exposure, all exposure times result in significantly 
reduced cell numbers (p < 0.05), with a 12.0% 
reduction for 1 minute, i7.5% for 3 minutes, 18.5% 
for 5 minutes, 33.4% for 10 minutes, and 58.6% 
reduction for 20 minutes. 
Effect of  Dilution of Contrast. Fig. 4, top 
graph, shows that EC exposed to full strength con- 
trast had a greater eduction in proliferation (44.0%, 
p < 0.05) compared with nonexposed control EC, 
cells exposed to ½ strength contrast (21.3%, NS 
compared with control), or ¼ strength contrast 
(i1.4%, NS compared with control) 24 hours after 
exposure. The difference in cell number between 
cells exposed to full strength and ½ strength contrast 
was significant (p <= 0.01) and between full strength 
and ¼ strength coetrast was significant (p = 0.03). 
However, by day 3 after exposure no significant dif- 
ference in cell number was observed. 
Fig. 4, bottom graph, demonstrates that SMC 
proliferation was decreased significantly only in cells 
exposed to full strength contrast. Twenty-four hours 
after exposure cell number decreased 41.1% (p < 
0.05), and although 3 days after exposure cell num- 
ber was reduced 29.3%, this was not statistically sig- 
nificant (p =0.17). Diluted contrast had no signifi- 
cant inhibitory effect on SMC growth at 1 or 3 days 
after exposure. 
Effect of  Osmolality. As shown in Fig. 5, EC 
proliferation was decreased 35.7% and 36.0% com- 
pared with control cells 24 hours after exposure to 
Conray, a 1400 mOsm/kg contrast agent, and 1400 
mOsm/kg mannitol, respectively. Three days after 
exposure, no significant difference was shown 
between the effect of Conray (29.4% reduction) and 
1400 mOsm/kg mannitol (40.3% reduction). The 
decrease in cell number 1 and 3 days after exposure 
to both Conray and 1400 mOsm/kg mannitol was 
significant compared with control cell number (p < 
0.05). 
EC proliferation decreased in direct proportion 
to increasing osmolality of mannitol test solutions. 
Fig. 5, bottom graph, shows that EC growth had 
the greatest decrease after exposure to 1400 
mOsm/kg mannitol (43.2% after 1 day, 36.9% after 
3 days), compared with 700 mOsm/kg (28.9% after 
1 day, 23.6% after 3 days), or 350 mOsm/kg (19.1% 
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Fig. 2. Lactate dehydrogenase (LDH) activity after 10- 
minute exposure to three different contrast agents. Top 
graph, LDH activity in EC media. Bottom graph, LDH 
activity in SMC media. Exposure to contrast did not 
increase LDH activity. 
after 1 day, 10.2% after 3 days). One day after expo- 
sure, all groups were significantly different from 
each other (p < 0.05). Three days after exposure, 
1400 mOsm/kg and 700 mOsm/kg mannitol con- 
tinue to show a significant decrease compared with 
controls (p < 0.05), but 350 mOsm/kg mannitol 
does not cause a significant decrease in cell number. 
Fig. 6, top graph, shows that SMC proliferation 
was more affected by exposure to 702 mOsm/kg 
Optiray than by exposure to 1400 mOsm/kg or 700 
mOsm/kg mannitol. Optiray exposure caused a 
48.2% decrease, 1400 mOsm/kg mannitol caused a 
25.3% decrease, and 700 mOsm/kg mannitol 
caused a 13.8% decrease in cell number 24 hours 
after exposure. The difference in cell number educ- 
tion between Optiray and control cells, as well as 
Optiray and both 1400 and 700 mOsm/kg manni- 
tol was significant (p < 0.05). Three days after expo- 
sure, Optiray, 1400 mOsm/kg and 700 mOsm/kg 
mannitol caused a 39.5%, a 15.6%, and a 3.6% 
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Hg. 3. Cell proliferation after varying exposure times. Cells were exposed to Conray for peri- 
ods of 1, 3, 5, 10, or 20 minutes. Data are mean + SEM. *p < 0.05 compared with control. 
Topgraph, EC proliferation. Proliferation was reduced as exposure time to contrast was pro- 
longed, Bottom graph, SMC proliferation. Similar pattern was observed in SMC proliferation, 
with significance at an exposure time of 10 minutes or longer. (p < 0.05). 
reduction in cell number, respectively. The cell 
reduction caused by both mannitol solutions was 
not significant compared with controls. The cell 
number reduction seen after Optiray exposure was 
significant compared with controls (p < 0.05), and 
compared with 1400 mOsm/kg (p < 0.05) and 700 
mOsm/kg mannitol (p < 0.05). 
SMC proliferation did not demonstrate a pro- 
portional decrease as osmolality of  the test solution 
was increased, as shown in Fig. 6, bottom graph. A 
1400 mOsm/kg mannitol solution decreased prolif- 
eration 23.9% 1 day after exposure and 11.0% 3 days 
after exposure compared with controls. The differ- 
ence at 1 day was significant (p < 0.05), but was not 
significant at 3 days. Neither 700 mOsm/kg manni- 
tol nor 350 mOsm/kg mannitol solutions had a sig- 
nificant effect on SMC proliferation 1 or 3 days after 
exposure. At day 1, a significant difference in prolif- 
eration was shown between cells exposed to i400 
mOsm/kg  mannitol and the 700 and 350 
mOsm/kg mannitol solutions (p < 0.05), but no dif- 
ference was noted between the effects of 700 and 
350 mOsm/kg solutions. At day 3, no significant 
difference was shown between the effects of i400, 
700, or 350 mOsm/kg  mannitol compared with 
each other or with control cells. 
Cell Structure Studies. The effect of contrast 
on the structure of  EC is shown in Fig. 7. 
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Fig. 4. Cell proliferation after exposure to dilutions of Conray contrast. Data are mean _+ 
SEM. *p < 0.05 compared with control. Topgraph, EC proliferation. Full strength contrast sig- 
nificantly reduces cell proliferation compared with ~ strength, which significantly reduces pro- 
liferation compared with ¼ strength at 24 hours after exposure. (p < 0.05 for all groups). 
Bottom graph, SMC proliferation. SMC proliferation is significantly reduced after exposure to 
fifll strength contrast. (p < 0.05). 
Endothelial control cells assume a cobblestone, con- 
fluent pattern by 72 hours typical of  EC cultures. 
EC exposed to Conray are spherical and display an 
injured structure with areas of  cell lifting immedi- 
ately after exposure. One hour after exposure, these 
changes are more severe, with larger areas of  cell 
detachment evident. By 24 hours, proliferation and 
cell structure have resumed a more normal appear- 
ance, but a few injured cells are still visible. By 72 
hours, the cells have resumed normal structure, sim- 
ilar to control cells. EC exposed to the nonionic 
agents Optiray and Isovue show smaller areas of cell 
detachment and less severe morphologic hanges 
immediately after contrast exposure. As seen with 
ionic contrast, injury becomes more severe at 1 hour 
after exposure. By 72 hours, both cell groups have 
resumed the normal cobblestone appearance typical 
of EC in culture. 
The effect of  contrast exposure on SMC struc- 
ture is shown in Fig. 8. Control SMC have a swirled, 
elongated structure with a confluent growth pattern 
at 72 hours. SMC exposed to Conray show mild cell 
injury initially, with more spherical, injured cells 
apparent 1hour after exposure. By 24 hours the cells 
have recovered, showing a swirled growth pattern 
similar to control cells by 72 hours. SMC exposed to 
Optiray show severe cell injury with large areas of 
cell lifting. All cells appear injured immediately and 
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Fig. 5. Comparison of effect of Conray and varying osmolar solutions of mannitol on EC. 
Cells were exposed to Conray or mannitol solution for10 minutes. Data are mean ± SEM. *p 
< 0.05 compared with control. Topgraph, EC were exposed to Conray and an isosmolar solu- 
tion ofmannitol. Bottom graph, EC were exposed to 1400, 700, or 350 mOsm/kg mannitol. 
Effect on proliferation i creased in proportion to increased osmolality. (p < 0.05). 
1 hour after exposure, with recovery seen 24 and 72 
hours after exposure. Changes een after exposure to 
Isovue are not as severe, with a few cells maintaining 
a normal structure. At 24 hours, a few cells contin- 
ue to show a spherical, abnormal shape, but many 
cells have recovered. At 72 hours, minimal cell 
injury is evident, and the cells have become conflu- 
ent in both groups. 
EC exposed to mannitol solutions (Fig. 9) show 
morphologic hanges proportional to the osmolality 
of  the mannitol solution. The most severe cell 
shrinkage is seen after exposure to 1400 mOsm/kg 
mannitol. Less cellular injury is evident after expo- 
sure to 700 mOsm/kg  mannitol. Minimal cell 
shrinkage is seen after exposure to 350 mOsm/kg 
mannitol. 
SMC exposed to mannitol solutions (Fig. 10) 
show minimal cell injury. After exposure to 1400 
mOsm/kg mannitol, very few spherical, injured cells 
are present. Cells exposed to 700 and 350 mOsm/kg 
mannitol appear normal. 
D ISCUSSION 
The results of this study support previous find- 
ings that brief contrast exposure causes acute injury 
to EC, but also demonstrates a long-term detrimen- 
tal effect on cell proliferation. EC undergo morpho- 
logic changes immediately after exposure to con- 
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Fig. 6. Comparison of effect of Optiray and varying osmolar solutions of mannitol on SMC. 
Data are mean + SEM. *p < 0.05 compared with control. Topgraph, SMC were exposed to 
Optiray, isosmolar,and hyperosmolar solution of mannitol. Optiray reduced cell proliferation 
significantly more than both isosmolar and hyperosmolar solutions. (p < 0.05). Bottom graph, 
SMC were exposed to 1400, 700, or 350 mOsm/kg mannitol. SMC proliferation was not 
dependent on osmolality. 
trast, most severe after high osmolar, ionic contrast 
exposure. EC were less affected by the lower osmo- 
lar nonionic agents. Not only do EC undergo acute 
injury, but their proliferation is markedly decreased 
for up to 7 days after brief exposure to contrast, indi- 
caring that the effect of  contrast may be longer-term 
than previously believed. Cell viability remains 
intact, as LDH levels never increased after contrast 
exposure, and widespread cell death did not appear 
to occur. The mechanism for EC injury may be 
highly dependent on the osmolality of the solution, 
as this study showed a direct correlation between 
increasing osmolality and decreasing proliferation. 
An in vitro cell culture model was used to investi- 
gate the effects of intravascular contrast on EC and 
SMC. Brief exposure to contrast in vivo can cause clin- 
ically apparent reactions and EC damage, but simulat- 
ing this exposure in vitro has several limitations. It is 
difficult to assess the precise concentration f contrast 
that contacts the endothelium in vivo, or the exact 
exposure time. In vivo, many other factors may con- 
tribute to the adverse ffect of contrast, such as hyper- 
glycemia, hyperlipidemia, renal failure, or other 
comorbid conditions. The effect may be multifactori- 
al, with different variables working synergistically to 
injure the endothelium. This study attempted to iso- 
late the effect of contrast as a single agent, without 
other contributing factors present. In many experi- 
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Control Conray 
Optiray Isovue 
Fig. 7. EC. A, EC immediately after washing or contrast exposure. B, EC after 1-hour incu- 
bation period. C, EC after 24 hours. D, EC after 72-hour incubation period. Photomicrograph 
×200 magnification. 
mental models, such as investigating the effects of  
homocysteine, it has been necessary to use higher lev- 
els or doses in an in vitro model to attain the effects 
seen in vivo, probably because of  the lack of  con- 
tributing factors present in an in vivo model. This 
study used the briefest half-life reported and the small- 
est dose of contrast sufficient to cover the EC layer in 
an attempt to maintain a clinically relevant model. 
Contrast agents have 3 to 10 times the osmolari- 
ty of serum, with ionic agents typically having a high- 
er osmolality than the nonionic agents. A linear rela- 
tionship between decreasing cell volume and increas- 
ing osmolality of  media was shown in cultured 
bovine pulmonary EC, indicating that the degree of 
cellular dehydration observed was dependent on the 
osmolality of  the extracellular fluid. 13 Th iss tudy 
demonstrated a similar linear relationship between 
decreasing EC proliferation and increasing osmolali- 
ty of  the test solution. Luh et al. 14 showed that 
bovine aortic EC exposed to media having higher 
than 460 mOsm/kg showed a significant decrease in 
cell viability and reduced cellular volume by 35% 
within 10 minutes of exposure. This study showed 
morphologic hanges consistent with osmotic cell 
injury immediately after exposure to high osmolar 
ionic contrast and high osmolar mannitol, support- 
ing hyperosmolar cell dehydration as the cause of the 
morphologic hanges een. The immediate morpho- 
logic changes were not as severe after EC exposure to 
low osmolar nonionic contrast or low osmolar man- 
nitol solutions. These findings were also confirmed 
when sorbitol was used instead of mannitol in some 
additional experiments. 
The effect of contrast on EC cannot, however, bc 
fully attributed to hyperosmolar cell injury. Some 
new ionic contrast agents with osmolalities equal to 
or less than nonionic agents exhibit greater toxicity in 
vivo and in vitro, and nonionic agents with the same 
osmolalities have been shown to have different cellu- 
lar toxicity.8,15 The toxicity of iodine was noted early 
in the development of contrast media, and groups 
were added to contrast molecules to shield the toxic 
iodine atoms and make contrast media more physio- 
logically tolerable. 16-18 After intravascular contrast 
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Control Conray 
Optiray Isovue 
Fig. 8. SMC. A, SMC immediately after washing or contrast exposure. B, SMC 1 hour after 
washing or contrast exposure. C, SMC after 24-hour incubation. D, SMC after 72 hours. 
Photomicrograph x200 magnification. 
injection, some of  the iodine is released as frec 
iodide, which can be oxidized to a free radical inter- 
mediate. This free radical release may be involved in 
the toxicity of intravenous contrast agents. 
Ionic and nonionic contrast agents have different 
effects clinically, and several studies have shown dif- 
ferential effects on EC protein expression and inter- 
cellular interaction. Alterations in expression of  
PGI2, P-selectin, and other EC proteins has been 
demonstrated after exposure to contrast media. 19-21 
Further studies need to investigate the expression of 
EC autocrine growth factors, intercellular and basal 
adhesion molecules, DNA synthesis, and vasoactive 
protein synthesis to better understand the mecha- 
nism by which ionic contrast inhibits EC growth. 
EC injury exposes the subendothelial e ements, 
including SMC, to circulating contrast, but the effect 
of direct contact between circulating contrast and 
SMC is poorly understood. Previous tudies have con- 
centrated on identifying possible mechanisms of 
vasodilation and vasospasm induced by intravascular 
contrast, 22-26 although little is lcrlown about its effects 
on SMC function and growth. This study shows that 
exposure of SMC to contrast agents causes a marked 
decrease in cell proliferation. SMCs are most severely 
affected by the nonionic agent Optiray, whereas the 
higher osmolar agent Conray had much less of an 
effect. Isovue, a nonionic agent with a similar osmo- 
lality to Optiray, did not decrease SMC proliferation 
to the degree seen with Optiray exposure. As with 
EC, LDH activity is not increased after exposure, so 
cell viability appears intact. SMC proliferation and 
morphologic hanges do not appear to be dependent 
on osmolality, as neither 1400 mOsm/kg nor 700 
mOsm/kg mannitol solutions decrease cell prolifera- 
tion or alter structure as markedly as 702 mOsm/kg 
Optiray. SMC showed no direct relationship between 
osmolality and proliferation. This effect does not 
appear to be due to the hyperosmolar nature of con- 
trast, but is perhaps due to other chemical character- 
istics of the contrast as previously described. 
Contrast media has been shown to affect vascu- 
lar SMC directly. Vasodilation of isolated rabbit aor- 
tic rings has been shown to be endothelium inde- 
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Fig. 9. EC 1 hour after 10-minute xposure to mannitol. A, Control EC demonstrate cob- 
blestone growth pattern typical of confluent EC in culture. B, EC exposed to 1400 mOsm/kg 
mannitol. Many injured, spherical cells are seen. C, EC exposed to 700 mOsm/kg mannitol. 
Cell shrinkage is evident, but not as extensive as seen with 1400 mOsm/kg mannitol. D, EC 
exposed to 350 mOsm/kg mannitol. Minimal cell injury is seen. Photomicrograph ×200 mag- 
nification. 
pendent, due to some direct action on the SMC, 
with isosmotic and hyperosmotic ontrast causing 
an equal vasodilatory effect. 22 The osmolality of  the 
solution had no influence on the effect of  the con- 
trast, consistent with the results o f  this study. 
Several studies have shown contrast to have a depo- 
larizing effect on vascular SMC and nerve terminals, 
with increased release of  norepinephrine, causing 
vasospasm. 23 This effect was blocked by calcium 
channel blocking agents, suggesting that contrast 
may activate calcium channcls. 24 Perhaps the mech- 
anism of  the effect of contrast on SMC in this study 
is mediated by ionic interaction at the cell mem- 
brane, as nonionic contrast seems to effect this 
more than ionic contrast and this effect seems inde- 
pendent of  osmolality. Alteration in EC prolifera- 
tion may be more dependent on expression of pro- 
tein factors and intercellular interaction. 
Contrast directly affects vascular SMC contrac- 
tile function, with different effects of ionic and non- 
ionic agents noted. Ionic contrast binds calcium, but 
nonionic contrast has minimal calcium binding 
properties, 2~ which may contribute to the different 
effects een with these agents. Schneider and Rand 26 
showed that vasoconstriction was due primarily to 
hyperosmolality, whereas dilation was probably due 
to elevations of  cAMP or cGMP. The differential 
effects of  contrast on growth and SMC structure 
may bc explained by the increased effects ofnonion- 
ic contrast on depolarization of the cell membrane, 
ineracellular ion alterations, and effects on intracellu- 
lar second messengers. Production of adhesion mol- 
ecules, alterations in cell to cell interactions, and 
expression of  cytoskeletal proteins also warrants 
investigation as contributing factors to the effect of 
nonionic contrast on SMC observed in this study. 
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Fig. 10. SMC 1 hour after 10-minute xposure to mannitol. A, Control SMC demonstrate 
confluent, swirled growth pattern. B, SMC exposed to 1400 mOsm/kg mannitol. Few dam- 
aged cells are evident with little cell lifting from the matrix. C, SMC exposed to 700 mOsm/kg 
mannitol. Cells appear normal with no evidence ofinjury. D, SMC exposed to 350 mOsm/kg 
mannitol. Cells also appear normal with no shrinkage. Photomicrograph x200 magnification. 
CONCLUSION 
Brief contrast exposure causes immediate EC 
injury, followed by up to 7 days of decreased prolif- 
eration of EC. This effect is dependent  on the osmo- 
lality of the contrast solution, and the length of the 
exposure period, with high osmolar solutions and 
pro longed exposure periods causing the greatest 
decrease in proliferation. SMC proliferation is also 
decreased after contrast exposure, but  appears to be 
independent  of osmolality. Both cell types show an 
ability to recover structurally by 24 hours after expo- 
sure, with proliferation starting to recover by 7 days 
after exposure. The adverse ffect of contrast agents 
on EC growth may be mediated by hyperosmolar 
cell injury, whereas SMC injury is likely to be due to 
a different mechanism. 
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DISCUSSION 
Dr. Jack Cronenwet t  (Lebanon, N.H.) .  That was a 
nice study, and I think I understand it. I would like to ask 
a question about the clinical relevance. I think o f  an 
endothelial cell as being exposed to a contrast bolus and 
passing quicldy in most settings and as certainly being 
somewhat diluted. As I understand it, you exposed these 
cells to straight contrast material for some considerable 
length o f  time. So, my question is, do you think your 
observations are clinically relevant, and if so, do you think 
it ought to change our practice in requiring the use of  
nonionic agents? 
Dr. Carol J. Sawmiller. I will address the first part of  
the clinical relevance. Some studies were done in the early 
1980s, with intact segments of  aorta in flow chambers. The 
investigators perfused contrast, and the aortas were then 
studied by means of  electron microscopy. Similar findings 
of  areas of  cells lifting off  of  the subendothelium and areas 
of  cell shrinkage were noted. Some in vivo studies were 
done in animals. The femoral arteries were then harvested 
and examined, and similar findings were noted. So, even 
though it is difficult to determine the dose of  contrast hat 
actually contacts the endothelium in vivo, I think our study 
showed findings similar to studies performed in vivo in ani- 
mals. There are many things that can cause cell injury, not 
just the contrast. Obviously, in an in vivo situation, we can- 
not study the effect of only contrast because many patients 
also have diabetes, high glucose levels, hyperlipidemia, nd 
estrogens. It is a multifactorial response. So, it is difficult in 
vivo to isolate the effect of  just contrast. We wanted to try 
to grossly identify the effect of  contrast and then eventual- 
ly try to narrow it to find a specific mechanism. 
As far as changing the practice of  which contrast we 
use, I would say that ideally everyone would get nonionic 
contrast, but the problem with that is the expense. Ionic 
contrast is 10 to 20 times cheaper than nonionic contrast, 
which now has become a big issue. We ideally would like 
to try to identify, or at least narrow down the mechanism, 
and then perhaps discover a better contrast agent or deter- 
mine if there is something we could administer with the 
contrast o decrease its toxicity. 
